These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2036258)

  • 1. [Neoadjuvant chemotherapy with cis-platin and 5-fluorouracil in continuous infusion (96 h.), in stages III and IV of carcinomas of the upper aerodigestive tract].
    Muñoz A; Bernal AG; Ramos A; Lavilla MJ; Martín A; Gómez JL; Cruz JJ; Nieto A; del Cañizo A
    Acta Otorrinolaringol Esp; 1991; 42(1):30-6. PubMed ID: 2036258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.
    Hitt R; López-Pousa A; Martínez-Trufero J; Escrig V; Carles J; Rizo A; Isla D; Vega ME; Martí JL; Lobo F; Pastor P; Valentí V; Belón J; Sánchez MA; Chaib C; Pallarés C; Antón A; Cervantes A; Paz-Ares L; Cortés-Funes H
    J Clin Oncol; 2005 Dec; 23(34):8636-45. PubMed ID: 16275937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant chemoradiotherapy for advanced head and neck cancer.
    Lin JC; Jan JS; Hsu CY
    Jpn J Clin Oncol; 1994 Apr; 24(2):94-100. PubMed ID: 8158863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Induction chemotherapy in the treatment of head and neck cancer in advanced stages].
    Balaña C; Massuti B; Minguell J; Talavera J; Sánchez B; Pico C
    Acta Otorrinolaringol Esp; 1992; 43(1):61-6. PubMed ID: 1581100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
    Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
    J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience.
    Papadimitrakopoulou VA; Dimery IW; Lee JJ; Perez C; Hong WK; Lippman SM
    Cancer J Sci Am; 1997; 3(2):92-9. PubMed ID: 9099459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
    Chang PM; Chen PM; Chu PY; Wang LW; Tai SK; Tsai TL; Huang JL; Wang YF; Chang SY; Yang MH
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):9-17. PubMed ID: 18343925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results.
    Hitt R; Hornedo J; Colomer R; Mendiola C; Brandariz A; Sevilla E; Alvarez-Vicent J; Cortés-Funes H
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):50-4. PubMed ID: 8643971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Radiotherapy plus a combination of cisplatin and 5-fluorouracil for locally advanced head and neck neoplasms. Study of feasibility and preliminary results].
    Colombo A; Crispino S; Tancini G; Personeni A; Taino R; Sarti E; Barni S; Lissoni P; Placa F; Mazzola P
    Radiol Med; 1990 Nov; 80(5):713-8. PubMed ID: 2267392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Four days' continuous infusion of cisplatin-5-fluorouracil and short daily infusion of high-dose leucovorin as induction chemotherapy for locally advanced head and neck cancer.
    Cruz JJ; Fonseca E; Muñoz A; Nieto A; Gomez A; Garcia J; Martin G; Sanchez P; Panadero A; Garcia MJ
    J Infus Chemother; 1995; 5(3):125-8. PubMed ID: 8528969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of chemotherapy (cisplatin and 5-FU) and radiotherapy in the management of advanced or recurrent head and neck cancer: a phase II study.
    Grimaldi A; Merlano M; Benasso M; Margarino G; Scasso F; Corvò R; Rosso R
    Chemioterapia; 1986 Oct; 5(5):356-9. PubMed ID: 3791484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combination of induction chemotherapy with surgery and/or radiotherapy in locally advanced head and neck cancers. A retrospective analysis of a series of 125 patients].
    Ray-Coquard I; Bolla M; Reyt E; Brochon D; Lebeau J; Colonna M; Kolodié H; Vincent F; Chinal-Provencal J
    Bull Cancer; 1997 Sep; 84(9):863-8. PubMed ID: 9435807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Split course hyperfractionated accelerated radio-chemotherapy (SCHARC) for patients with advanced head and neck cancer: influence of protocol deviations and hemoglobin on overall survival, a retrospective analysis.
    Stadler P; Putnik K; Kreimeyer T; Sprague LD; Koelbl O; Schäfer C
    BMC Cancer; 2006 Dec; 6():279. PubMed ID: 17150114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of simultaneous radio-polychemotherapy in advanced inoperable cancer of the head and neck].
    Wustrow TP; Wendt TG; Schalhorn A
    Laryngol Rhinol Otol (Stuttg); 1988 Nov; 67(11):567-75. PubMed ID: 3266283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisplatin and 5-fluorouracil in recurrent head and neck cancer: results of an outpatient schedule.
    Airoldi M; Pedani F; Brando V; Giordano C; Gabriele P
    Chemioterapia; 1988 Apr; 7(2):127-9. PubMed ID: 3396116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant administration of two standard regimens of chemotherapy and radiotherapy in advanced squamous carcinoma of the head and neck: a feasibility study.
    Benasso M; Corvò R; Numico G; Cavallari M; Blengio F; Sanguineti G; Rosso M; Merlano M
    Anticancer Res; 1995; 15(6B):2651-4. PubMed ID: 8669841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007.
    Worden FP; Moon J; Samlowski W; Clark JI; Dakhil SR; Williamson S; Urba SG; Ensley J; Hussain MH;
    Cancer; 2006 Jul; 107(2):319-27. PubMed ID: 16779801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late chemo-intensification with cisplatin and 5-fluorouracil as an adjunct to radiotherapy: a pragmatic approach for locally advanced head and neck squamous cell carcinoma.
    Chufal KS; Rastogi M; Srivastava M; Pant MC; Bhatt ML
    Oral Oncol; 2006 May; 42(5):517-25. PubMed ID: 16480913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck. A long-term analysis for the Illinois Cancer Center.
    Athanasiadis I; Taylor S; Vokes EE; Pelzer HJ; Rademaker A; Mittal BB; Ganzenko N; Blough R; Lester EP; Kies MS
    Cancer; 1997 Feb; 79(3):588-94. PubMed ID: 9028372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of hyperfractionation and conventional fractionation radiotherapy with concurrent docetaxel, cisplatin and 5-fluorouracil (TPF) chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
    Katori H; Tsukuda M; Watai K
    Cancer Chemother Pharmacol; 2007 Aug; 60(3):399-406. PubMed ID: 17096160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.